AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionBbr Partners, Llc
Latest Disclosed Ownership53,617 shares
Latest Disclosed Value $ 11,661,161
Bbr Partners, Llc reports 1.16% decrease in ownership of 4AB / AbbVie Inc.

On May 12, 2026 - Bbr Partners, Llc filed a 13F-HR form disclosing ownership of 53,617 shares of AbbVie Inc. (DE:4AB) valued at $9,940,592 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 54,246 shares of AbbVie Inc.. This represents a change in shares of -1.16% during the quarter. The current value of the position is $10,106,804 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE COM 00287Y109 53,617 -629 -1.16 11,661 -5.91 0.6508
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 54,246 -77 -0.14 12,395 -1.46 0.6651
2025-11-07 2025-09-30 13F ABBVIE COM 00287Y109 54,323 79 0.15 12,578 24.92 0.7252
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 54,244 -4,280 -7.31 10,069 -17.89 0.6268
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 58,524 -9 -0.02 12,262 17.88 0.8660
2025-02-07 2024-12-31 13F ABBVIE COM 00287Y109 58,533 -2,932 -4.77 10,401 -14.31 0.7259
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 61,465 6,578 11.98 12,138 28.94 0.9250
2024-08-05 2024-06-30 13F AbbVie COM 00287Y109 54,887 -8,162 -12.95 9,414 -18.00 0.7713
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 63,049 7,144 12.78 11,481 32.53 0.9197
2024-02-13 2023-12-31 13F ABBVIE COM 00287Y109 55,905 603 1.09 8,664 5.10 0.8856
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 55,302 3,394 6.54 8,243 17.88 0.9272
2023-08-08 2023-06-30 13F ABBVIE COM 00287Y109 51,908 -209 -0.40 6,994 -15.80 0.7739
2023-05-11 2023-03-31 13F ABBVIE COM 00287Y109 52,117 -85 -0.16 8,306 -1.55 0.9572
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 52,202 54 0.10 8,436 20.53 0.9486
2022-11-10 2022-09-30 13F ABBVIE COM 00287Y109 52,148 -2,488 -4.55 6,999 -16.36 0.8967
2022-08-12 2022-06-30 13F ABBVIE COM 00287Y109 54,636 -500 -0.91 8,368 -6.38 0.9778
2022-05-16 2022-03-31 13F ABBVIE COM 00287Y109 55,136 16,445 42.50 8,938 70.61 0.8429
2022-02-08 2021-12-31 13F ABBVIE COM 00287Y109 38,691 167 0.43 5,239 26.06 0.6155
2021-11-12 2021-09-30 13F ABBVIE COM 00287Y109 38,524 -2,940 -7.09 4,156 -11.03 0.3438
2021-08-13 2021-06-30 13F ABBVIE COM 00287Y109 41,464 -343 -0.82 4,671 3.25 0.3692
2021-05-17 2021-03-31 13F ABBVIE COM 00287Y109 41,807 26 0.06 4,524 1.05 0.3716
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 41,781 84 0.20 4,477 22.59 0.3710
2020-11-12 2020-09-30 13F ABBVIE COM 00287Y109 41,697 3,267 8.50 3,652 -3.21 0.3129
2020-08-11 2020-06-30 13F ABBVIE COM 00287Y109 38,430 -2,891 -7.00 3,773 19.85 0.4762
2020-05-14 2020-03-31 13F ABBVIE COM 00287Y109 41,321 315 0.77 3,148 -13.30 0.4685
2020-02-14 2019-12-31 13F ABBVIE COM 00287Y109 41,006 -26 -0.06 3,631 16.87 0.3976
2019-11-12 2019-09-30 13F ABBVIE COM 00287Y109 41,032 41 0.10 3,107 4.23 0.4736
2019-08-14 2019-06-30 13F ABBVIE COM 00287Y109 40,991 0 0.00 2,981 -9.75 0.4766
2019-05-10 2019-03-31 13F ABBVIE COM 00287Y109 40,991 0 0.00 3,303 -12.60 0.4290
2019-02-08 2018-12-31 13F ABBVIE COM 00287Y109 40,991 0 0.00 3,779 -2.53 0.4974
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 40,991 700 1.74 3,877 3.86 0.5604
2018-08-14 2018-06-30 13F ABBVIE COM 00287Y109 40,291 36,070 854.54 3,733 833.25 0.6278
2018-05-09 2018-03-31 13F ABBVIE COM 00287Y109 4,221 4,221 400 0.0715
2017-02-10 2016-12-31 13F ABBVIE COM 00287Y109 0 0 0 0.0000
2016-11-14 2016-09-30 13F ABBVIE COM 00287Y109 0 -4,150 -100.00 0 -100.00
2016-08-12 2016-06-30 13F ABBVIE COM 00287Y109 4,150 4,150 257 0.0428
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.